PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced that it has acquired the rights to an exclusive, worldwide license for a technology dedicated to the prognosis of adolescent scoliosis using 3D and 2D clinical parameters obtained from EOS®...
More...
